{"product_id":"rps6kb1-antibody-sc-f0011","title":"p70 S6 Kinase Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eRPS6KB1 is a target of interest in many antibody-based workflows. The p70 Ribosomal protein S6 kinase 1 (S6K1, p70S6K) is part of the AGC subfamily of serine\/threonine protein kinases, which includes cyclic AMP-dependent protein kinase, cyclic GMP-dependent protein kinase, and protein kinase C. The S6K family is located on chromosome 17q23. Through alternative splicing and different translational start sites, the human S6K1 gene produces two isoforms: p70 and p85. Depending on the literature source, RPS6KB1 may also be discussed as p70 S6 Kinase and p70 S6 kinase alpha.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cytoplasm, membrane, mitochondrion, and mitochondrion outer membrane, which can matter when signal is compared across treatments or changing cell states. Following RPS6KB1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eRPS6KB1 is commonly interpreted in the context of cancer, metabolism, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, membrane, and mitochondrion, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cytoplasm, membrane, and mitochondrion across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003eresponses linked to nutrient status, mitochondrial state, or metabolic rewiring\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for RPS6KB1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in RPS6KB1 reflect biology rather than handling. When interpreting RPS6KB1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep RPS6KB1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577379660121,"sku":"F0011-20UL","price":149.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577379692889,"sku":"F0011-100UL","price":369.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577379725657,"sku":"F0011-2X100UL","price":549.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F0011-IHC1.jpg?v=1773598077","url":"https:\/\/absource.de\/products\/rps6kb1-antibody-sc-f0011","provider":"Absource Diagnostics","version":"1.0","type":"link"}